{"id":39455,"date":"2026-03-27T01:04:21","date_gmt":"2026-03-27T01:04:21","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/39455\/"},"modified":"2026-03-27T01:04:21","modified_gmt":"2026-03-27T01:04:21","slug":"roche-hires-novo-executive-to-help-push-into-obesity-drug-market","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/39455\/","title":{"rendered":"Roche Hires Novo Executive to Help Push Into Obesity Drug Market"},"content":{"rendered":"<p class=\"ArticleBodyText_articleBodyContent__17wqE typography_articleBody___5jDr\" data-component=\"paragraph\"><a href=\"https:\/\/www.bloomberg.com\/quote\/ROG:SW\" target=\"_blank\" rel=\"noopener nofollow\" class=\"media-ui-Link_link-tVkXhPLPofs-\" data-component=\"link\">Roche Holding AG<\/a> hired a senior executive from rival Novo Nordisk A\/S as the Swiss drugmaker prepares to enter the hyper-competitive market for obesity drugs. <\/p>\n<p class=\"ArticleBodyText_articleBodyContent__17wqE typography_articleBody___5jDr\" data-component=\"paragraph\"><a href=\"https:\/\/www.linkedin.com\/in\/morten-lammert-1374621\/\" title=\"LinkedIn Page\" target=\"_blank\" rel=\"noopener nofollow\" class=\"media-ui-Link_link-tVkXhPLPofs-\" data-component=\"link\">Morten Lammert<\/a> will join Roche as its global therapeutic area head for cardiovascular, renal and metabolism on June 1, a spokesman for the company said. The role, which focuses on the commercial market rather than on research and development, did not previously exist at Roche.<\/p>\n","protected":false},"excerpt":{"rendered":"Roche Holding AG hired a senior executive from rival Novo Nordisk A\/S as the Swiss drugmaker prepares to&hellip;\n","protected":false},"author":2,"featured_media":39456,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[22207,10404,4397,13224,197,4128,23121,10622,13225,304,134,13222],"class_list":["post-39455","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-americas","tag-carmot-therapeutics-inc","tag-drugs","tag-eli-lilly-co","tag-europe","tag-healthcare","tag-industrials","tag-industries","tag-novo-nordisk-a-s-b","tag-pharmaceutical","tag-roche","tag-roche-holding-ag-genusschein"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116298452974847612","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/39455","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=39455"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/39455\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/39456"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=39455"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=39455"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=39455"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}